Introduction of Penthrox® (methoxyflurane) International Named Patient Program
Through a partnership that has been established between MDI and IDIS, healthcare professionals are now able to readily access Penthrox® (methoxyflurane) in response to patients in need, whilst ensuring the medicine is used appropriately. IDIS is a U.K. based organisation that specialises in the management and distribution of unlicensed medicines on a named-patient / compassionate use basis. Healthcare professionals who would like to obtain Penthrox® (methoxyflurane) for a specific patient can obtain the medicine on a named-patient / compassionate use basis by contacting IDIS directly.
IDIS will provide you with full details on how to obtain the product, and where appropriate, assist you with the requirements for import and use of Penthrox® (methoxyflurane) in your country.